Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study - PubMed (original) (raw)
Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study
H Cortez-Pinto et al. JAMA. 1999.
Abstract
Context: The mechanisms that drive progression from fatty liver to steatohepatitis and cirrhosis are unknown. In animal models, obese mice with fatty livers are vulnerable to liver adenosine triphosphate (ATP) depletion and necrosis, suggesting that altered hepatic energy homeostasis may be involved.
Objective: To determine if patients with fatty liver disease exhibit impaired recovery from hepatic ATP depletion.
Design: Laboratory analysis of liver ATP stores monitored by nuclear magnetic resonance spectroscopy before and after transient hepatic ATP depletion was induced by fructose injection. The study was conducted between July 15 and August 30, 1998.
Setting: University hospital.
Patients: Eight consecutive adults with biopsy-proven nonalcoholic steatohepatitis and 7 healthy age- and sex-matched controls.
Main outcome measure: Level of ATP 1 hour after fructose infusion in patients vs controls.
Results: In patients, serum aminotransferase levels were increased (P = .02 vs controls); albumin and bilirubin values were normal and clinical evidence of portal hypertension was absent in both groups. However, 2 patients had moderate fibrosis and 1 had cirrhosis on liver biopsy. Mean serum glucose, cholesterol, and triglyceride levels were similar between groups but patients weighed significantly more than controls (P = .02). Liver ATP levels were similar in the 2 groups before fructose infusion and decreased similarly in both after fructose infusion (P = .01 vs initial ATP levels). However, controls replenished their hepatic ATP stores during the 1-hour follow-up period (P<.02 vs minimum ATP) but patients did not. Hence, patients' hepatic ATP levels were lower than those of controls at the end of the study (P = .04). Body mass index (BMI) correlated inversely with ATP recovery, even in controls (R = -0.768; P = .07). Although BMI was greater in patients than controls (P = .02) and correlated strongly with fatty liver and serum aminotransferase elevations, neither of the latter 2 parameters nor the histologic severity of fibrosis strongly predicted hepatic ATP recovery.
Conclusions: These data suggest that recovery from hepatic ATP depletion becomes progressively less efficient as body mass increases in healthy controls and is severely impaired in patients with obesity-related nonalcoholic steatohepatitis.
Similar articles
- Hepatic ATP reserve and efficiency of replenishing: comparison between obese and nonobese normal individuals.
Nair S, P Chacko V, Arnold C, Diehl AM. Nair S, et al. Am J Gastroenterol. 2003 Feb;98(2):466-70. doi: 10.1111/j.1572-0241.2003.07221.x. Am J Gastroenterol. 2003. PMID: 12591070 - No difference between high-fructose and high-glucose diets on liver triacylglycerol or biochemistry in healthy overweight men.
Johnston RD, Stephenson MC, Crossland H, Cordon SM, Palcidi E, Cox EF, Taylor MA, Aithal GP, Macdonald IA. Johnston RD, et al. Gastroenterology. 2013 Nov;145(5):1016-1025.e2. doi: 10.1053/j.gastro.2013.07.012. Epub 2013 Jul 19. Gastroenterology. 2013. PMID: 23872500 Clinical Trial. - Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes.
Abdelmalek MF, Lazo M, Horska A, Bonekamp S, Lipkin EW, Balasubramanyam A, Bantle JP, Johnson RJ, Diehl AM, Clark JM; Fatty Liver Subgroup of Look AHEAD Research Group. Abdelmalek MF, et al. Hepatology. 2012 Sep;56(3):952-60. doi: 10.1002/hep.25741. Epub 2012 Jul 12. Hepatology. 2012. PMID: 22467259 Free PMC article. - Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach.
Hookman P, Barkin JS. Hookman P, et al. Am J Gastroenterol. 2003 Sep;98(9):2093-7. doi: 10.1111/j.1572-0241.2003.07670.x. Am J Gastroenterol. 2003. PMID: 14499793 Review. - Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease.
Koliaki C, Roden M. Koliaki C, et al. Mol Cell Endocrinol. 2013 Oct 15;379(1-2):35-42. doi: 10.1016/j.mce.2013.06.002. Epub 2013 Jun 12. Mol Cell Endocrinol. 2013. PMID: 23770462 Review.
Cited by
- Beneficial effects of MGL-3196 and BAM15 combination in a mouse model of fatty liver disease.
Zhou M, Li C, Byrne FL, Vancuylenburg CS, Olzomer EM, Hargreaves A, Wu LE, Shackel NA, Santos WL, Hoehn KL. Zhou M, et al. Acta Physiol (Oxf). 2024 Oct;240(10):e14217. doi: 10.1111/apha.14217. Epub 2024 Aug 16. Acta Physiol (Oxf). 2024. PMID: 39152636 - Metabolic inflexibility promotes mitochondrial health during liver regeneration.
Wang X, Menezes CJ, Jia Y, Xiao Y, Venigalla SSK, Cai F, Hsieh MH, Gu W, Du L, Sudderth J, Kim D, Shelton SD, Llamas CB, Lin YH, Zhu M, Merchant S, Bezwada D, Kelekar S, Zacharias LG, Mathews TP, Hoxhaj G, Wynn RM, Tambar UK, DeBerardinis RJ, Zhu H, Mishra P. Wang X, et al. Science. 2024 Jun 14;384(6701):eadj4301. doi: 10.1126/science.adj4301. Epub 2024 Jun 14. Science. 2024. PMID: 38870309 Free PMC article. - Post-Liver Transplant Metabolic Syndrome.
Choudhury A, Singh SP, Desmukh A, Sahoo B, Eslam M. Choudhury A, et al. J Clin Exp Hepatol. 2024 Jul-Aug;14(4):101368. doi: 10.1016/j.jceh.2024.101368. Epub 2024 Feb 29. J Clin Exp Hepatol. 2024. PMID: 38523736 - Relationship between serum β-hydroxybutyrate and hepatic fatty acid oxidation in individuals with obesity and NAFLD.
Moore MP, Shryack G, Alessi I, Wieschhaus N, Meers GM, Johnson SA, Wheeler AA, Ibdah JA, Parks EJ, Rector RS. Moore MP, et al. Am J Physiol Endocrinol Metab. 2024 Apr 1;326(4):E493-E502. doi: 10.1152/ajpendo.00336.2023. Epub 2024 Feb 21. Am J Physiol Endocrinol Metab. 2024. PMID: 38381399 - Associations of Skeletal Muscle Mass, Muscle Fat Infiltration, Mitochondrial Energetics, and Cardiorespiratory Fitness With Liver Fat Among Older Adults.
Igudesman D, Mucinski J, Harrison S, Cawthon PM, Linge J, Goodpaster BH, Cummings SR, Hepple RT, Jurczak MJ, Kritchevsky SB, Marcinek D, Coen PM, Corbin KD. Igudesman D, et al. J Gerontol A Biol Sci Med Sci. 2024 Apr 1;79(4):glae047. doi: 10.1093/gerona/glae047. J Gerontol A Biol Sci Med Sci. 2024. PMID: 38366047
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources